MATTAREI, ANDREA
MATTAREI, ANDREA
Dipartimento di Scienze del Farmaco - DSF
Design, Synthesis, and Pharmacokinetic Profiling of Fluorinated Reversible N-Alkyl Carbamate Derivatives of Psilocin for Sub-Hallucinogenic Brain Exposure
2026 Banzato, Marco; Colognesi, Martina; Lucatello, Lorena; Comai, Stefano; Pasut, Gianfranco; Capolongo, Francesca; Orian, Laura; Biasutto, Lucia; Signor, Anna; Gabbia, Daniela; Manfredi, Paolo L.; De Martin, Sara; Mattarei, Andrea
Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanisms
2026 Colognesi, Martina; Gabbia, Daniela; Signor, Anna; Sarill, Miles; Centofanti, Lucia; Rinaldi, Andrea; Cascione, Luciano; Nunziata, Sara; Banzato, Marco; Mattarei, Andrea; Finzi, Giovanna; Sonda, Sonia; Pendin, Diana; Zanotto, Ilaria; Comai, Stefano; Pasut, Gianfranco; Alajati, Abdullah; Saponaro, Miriam; Bucciarelli, Loredana; Lunati, Maria Elena; Guarato, Giulia; Goggi, Ilaria; La Rosa, Stefano; Morano, Camillo; Paroni, Rita Clara; Dei Cas, Michele; Daniele, Giuseppe; Gentilucci, Marco; Pappagallo, Marco; Alimonti, Andrea; Manfredi, Paolo L.; Folli, Franco; De Martin, Sara
TSC-associated microglial hyperactivity: enhanced calcium signaling, metabolism, and phagocytosis
2026 Kalf, Rozemarijn S.; Luinenburg, Mark J.; Dematteis, Giulia; Scheper, Mirte; Anink, Jasper J.; Cavallo, Giulia; Mattarei, Andrea; Van Hecke, Wim; Mühlebner, Angelika; Tapella, Laura; Mills, James D.; Lim, Dmitry; Aronica, Eleonora
Tumor-specific targeting of a mitochondrial Kv1.3 channel inhibitor through conjugation to gastrin/cholecystokinin B receptor ligand strongly reduces pancreatic ductal adenocarcinoma in orthotopic models
2026 Parrasia, S.; Paoli, C.; Varanita, T.; Brillo, V.; Abdel-Salam, M. A. L.; Ongaro, A.; Honisch, C.; Angi, B.; Bachmann, M.; Bergamin, F.; Corbo, V.; Fiorini, E.; Rossa, A.; Bossio, G.; Gulbins, E.; Carrer, A.; Zoratti, M.; Mattarei, A.; Ruzza, P.; Biasutto, L.; Szabo, I.
ANXIOLYTIC- AND PROCOGNITIVE-LIKE EFFECTS OF A 30-DAY CHRONIC TREATMENT WITH A LOW NON-PSYCHEDELIC DOSE OF PSILOCYBIN IN C57BL/6J MICE
2025 Nasini, Sofia; Tidei, Sara; Barzon, Benedetta; De Martin, Sara; Banzato, Marco; Mattarei, Andrea; Folli, Franco; Pappagallo, Marco; Manfredi, Paolo L; Comai, Stefano
Dexamethasone conjugation to an Avidin-Nucleic-Acid-NanoASsembly eliminates the steroid plasma absorption, enhancing selective lung tropism in a murine model of pulmonary fibrosis
2025 Morelli, Annalisa; Schiavon, Elisa; Violatto, Martina Bruna; Moscatiello, Giulia Yuri; Salmaso, Anita; Passoni, Alice; Lanno, Alessia; Bernardotto, Simone; Stocco, Martina; Mattarei, Andrea; Bagnati, Renzo; Meloni, Federica; Bigini, Paolo; Morpurgo, Margherita
Emerging mechanisms of psilocybin-induced neuroplasticity
2025 Sonda, Sonia; Pendin, Diana; Comai, Stefano; De Martin, Sara; Manfredi, Paolo; Mattarei, Andrea
Esmethadone (REL-1017) in Patients With Major Depressive Disorder and Antidepressant Tachyphylaxis
2025 Guidetti, Clotilde; Papakostas, George I.; Pani, Luca; Martin, Sara De; Serra, Giulia; Apicella, Massimo; Kröger, Cornelia; Champasa, Paggard; Comai, Stefano; Mattarei, Andrea; Folli, Franco; Pappagallo, Marco; Manfredi, Paolo L.; Fava, Maurizio
Long-Term Safety and Efficacy of Esmethadone in Patients With Major Depressive Disorder
2025 Fava, Maurizio; Pani, Luca; Martin, Sara De; Cutler, Andrew J.; Gorodetzky, Charles W.; Vocci, Frank J.; Sapienza, Frank L.; Kosten, Thomas R.; Kröger, Cornelia; Champasa, Paggard; Guidetti, Clotilde; Comai, Stefano; Mattarei, Andrea; Folli, Franco; Bushnell, David; Traversa, Sergio; Inturrisi, Charles E.; Manfredi, Paolo L.; Pappagallo, Marco
Mitapivat metabolically reprograms human β-thalassemic erythroblasts, increasing their responsiveness to oxidation
2025 Siciliano, Angela; D'Alessandro, Angelo; Matte, Alessandro; Bisello, Giovanni; Bertoldi, Mariarita; Dzieciatkowska, Monika; Argabright, Amy; Pozzetto, Richard Huot; Riccardi, Veronica; Mattarei, Andrea; Ongaro, Alberto; Ceolan, Jacopo; Russo, Roberta; Rivadeneyra, Leonardo; Wind-Rotolo, Megan; Iolascon, Achille; Brugnara, Carlo; De Franceschi, Lucia
Mito-Genipin, a Novel Mitochondria-Targeted Genipin Derivative Modulates Oxidative Stress and Inflammation in Macrophages
2025 Angi, Beatrice; Di Molfetta, Daria; Pendin, Diana; Antoniazzi, Giuseppe; Alberto Flora, Carlo; De Leonardis, Francesco; Buono, Martina; Fiermonte, Giuseppe; Szabo, Ildiko; Mattarei, Andrea; Varanita, Tatiana
Mitochondrial calcium uptake declines during aging and is directly activated by oleuropein to boost energy metabolism and skeletal muscle performance
2025 Gherardi, Gaia; Weiser, Anna; Bermont, Flavien; Migliavacca, Eugenia; Brinon, Benjamin; Jacot, Guillaume E.; Hermant, Aurélie; Sturlese, Mattia; Nogara, Leonardo; Vascon, Filippo; De Mario, Agnese; Mattarei, Andrea; Garratt, Emma; Burton, Mark; Lillycrop, Karen; Godfrey, Keith M.; Cendron, Laura; Barron, Denis; Moro, Stefano; Blaauw, Bert; Rizzuto, Rosario; Feige, Jerome N.; Mammucari, Cristina; De Marchi, Umberto
New Synthesis and Pharmacological Evaluation of Enantiomerically Pure (R)- and (S)-Methadone Metabolites as N-Methyl-d-aspartate Receptor Antagonists
2025 Banzato, Marco; Furlan, Alberto; Locatelli, Patrizia; Sgrignani, Jacopo; Ongaro, Alberto; Dolmella, Alessandro; De Martin, Sara; Comai, Stefano; Cavalli, Andrea; Inturrisi, Charles; Bettini, Ezio; Manfredi, Paolo L.; Mattarei, Andrea
Reasons for Maintaining the Classification of Esmethadone as an Investigational Uncompetitive NMDAR Antagonist Rapid Antidepressant
2025 Martin, Sara De; Comai, Stefano; Mattarei, Andrea; Kosten, Thomas R.; Vocci, Frank J.; Gorodetzky, Charles W.; Pappagallo, Marco; Manfredi, Paolo L.
Selective inhibition of mitochondrial Kv1.3 prevents and alleviates multiple sclerosis in vivo
2025 Angi, B.; Varanita, T.; Puthenparampil, M.; Scattolini, V.; Donadon, M.; Tavakoli, M.; Favero, M.; El Boustani, M.; Soddemann, M.; Biasutto, L.; Arcidiacono, D.; Ongaro, A.; Mattarei, A.; Trentin, L.; Wilson, G.; Gulbins, E.; Gallo, P.; Szabo, I.
Small molecule OPA1 inhibitors amplify cytochrome c release and reverse cancer cells resistance to Bcl-2 inhibitors
2025 Pellattiero, Anna; Quirin, Charlotte; Magrin, Federico; Sturlese, Mattia; Fracasso, Alberto; Biris, Nikolaos; Herkenne, Stéphanie; Cendron, Laura; Gavathiotis, Evripidis; Moro, Stefano; Mattarei, Andrea; Scorrano, Luca
Small-molecule OPA1 inhibitors reverse mitochondrial adaptations to overcome therapy resistance in acute myeloid leukemia
2025 La Vecchia, S.; Doshi, S.; Antonoglou, P.; Kundu, T.; Al Santli, W.; Avrampou, K.; Witkowski, M. T.; Pellattiero, A.; Magrin, F.; Ames, K.; Verma, A.; Gritsman, K.; Su, X.; Mattarei, A.; Aifantis, I.; Scorrano, L.; Glytsou, C.
The Role of Structural Dispersity of Polymer Brushes in Determining the Colloidal Stability of Core–Shell Nanoparticles and Their Interaction with Anti-PEG Antibodies
2025 Pavón, Carlos; Grigoletto, Antonella; Kempkes, Verena; Eguskiza, Ander; Morbidelli, Maria; Fiammengo, Roberto; Papini, Emanuele; Mattarei, Andrea; Pasut, Gianfranco; Matyjaszewski, Krzysztof; Lorandi, Francesca; Benetti, Edmondo M.
A novel mertansine conjugate for acid-reversible targeted drug delivery validated through the Avidin-Nucleic-Acid-NanoASsembly platform
2024 Schiavon, Elisa; Rezzola, Sara; Filippi, Erica; Turati, Marta; Parrasia, Sofia; Bernardotto, Simone; Stocco, Martina; Szabò, Ildiko; Mattarei, Andrea; Ronca, Roberto; Morpurgo, Margherita
Drug–Drug Interaction Studies of Esmethadone (REL-1017) Involving CYP3A4- and CYP2D6-Mediated Metabolism
2024 Ferri, N.; De Martin, S.; Stuart, J.; Traversa, S.; Folli, F.; Pappagallo, M.; O’Gorman, C.; Guidetti, C.; Mattarei, A.; Inturrisi, C. E.; Manfredi, P. L.